About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mobility Assessment in Multi-morbidity | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT06473168

Mobility Assessment in Multi-morbidity

Multimorbidity (the presence of two or more coexisting long-term conditions) is a significant challenge facing the NHS, especially given UK's ageing population and the association with high levels of ...

Lead sponsor: Northumbria University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ioannis Vogiatzis, PhD

CONTACT

+44 (0)191 349 5446 [email protected]

Sponsors

Lead Sponsor

Northumbria University

Collaborators

Newcastle University

Age

65 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults ≥65 years old
•Able and willing to provide informed consent
•Able to read and write in English
•To be mobile (including the use of walking aids)
•Two or more of the following long terms conditions: Arthritis, Asthma, Atrial fibrillation, Bronchiectasis, Cancer, Chronic kidney disease, Chronic obstructive pulmonary disease, Coronary heart disease, Anxiety, Depression, Diabetes mellitus, Heart failure, Hypertension, Osteoporosis, Parkinson's disease, Peripheral vascular disease, Stroke or transient ischaemic attack

Exclusion Criteria

•Unable to give consent for the study
•Severe mental health problems
•Active malignancy (on chemotherapy/radiotherapy/planned urgent surgery)

Related studies

RECRUITINGPhase 2

Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

NCT07301736 · Asthma

RECRUITINGPhase 3

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

NCT07430956 · Atrial Fibrillation (AF)

RECRUITINGPhase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · Psoriatic Arthritis

RECRUITINGPhase 3

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

NCT07226258 · Osteoarthritis Knee Pain

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

NCT07527299 · Atrial Fibrillation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 25, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment55

Start dateDec 2024

Last updatedJun 25, 2024

Condition

Arthritis Asthma Atrial Fibrillation Bronchiectasis Cancer+13 more

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions